Table 3.
Intervention group, n = 20 | Control group, n = 17 | Between-group differences in mean change from baseline | ||||
---|---|---|---|---|---|---|
Variables | Baseline | 16-week follow-up | Baseline | 16-week follow-up | Δ (95% CI) | p |
VO2peak (ml/kg/min) | 23.4 (6.0) | 26.0 (7.0) | 26.6 (6.6) | 25.7 (6.1) | – 4.2 (– 6.7; – 1.8) | 0.001 |
VO2peak (ml/min) | 1,636 (449) | 1,893 (533) | 1,821 (559) | 1,717 (650) | – 352 (– 609; – 94) | 0.007 |
RER | 1.22 (0.11) | 1.18 (0.08) | 1.20 (0.10) | 1.20 (0.09) | 0.03 (– 0.02; 0.08) | 0.258 |
HRmax (bpm) | 141 (22) | 141 (23) | 146 (19) | 150 (21) | 2.7 (– 6.3; 11.5) | 0.560 |
Body weight (kg) | 73.6 (15.5) | 73.8 (15.8) | 68.2 (12.7) | 70.5 (10.4) | 1.2 (– 3.1; 5.5) | 0.583 |
Baseline and 16-week follow-up with unadjusted means±SD and mean outcomes of the Intervention Group compared to mean outcomes in Control Group, beyond the difference already present at baseline, adjusted for clustering within training groups and centers, RER: respiratory exchange ratio, HRmax: maximal heart rate.